The proposed bill, General Assembly Proposed Bill No. 6097, aims to enhance transparency regarding prescription drug discounts provided under Section 340B of the Public Health Service Act. It mandates that pharmacy benefit managers, pharmacies, insurers, and hospitals that dispense or provide coverage for these discounted drugs must file a report with the Office of Health Strategy. This report will detail the costs charged to consumers for any discounted prescription drugs, ensuring that consumers are aware of the pricing and benefits associated with these discounts.

The primary objective of this legislation is to protect consumers from overpaying for prescription drugs and to prevent premature enrollment in Medicaid due to income deductions related to drug costs. By requiring the reporting of these costs, the bill seeks to promote fairness and transparency in the healthcare system, ultimately benefiting consumers who rely on discounted medications.